The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MacIntyre, E. A.
Right arrow Articles by Linch, D. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MacIntyre, E. A.
Right arrow Articles by Linch, D. C.

The Journal of Immunology, Vol 142, Issue 7 2377-2383, Copyright © 1989 by American Association of Immunologists

ARTICLES

Activation of human monocytes occurs on cross-linking monocytic antigens to an Fc receptor

EA MacIntyre, PJ Roberts, M Jones, CE Van der Schoot, EJ Favalaro, N Tidman and DC Linch
Department of Haematology, Middlesex Medical School, London, UK.

Murine mAb to CD13, CD14, and class II MHC, are able to mobilize calcium in normal human monocytes and enhance superoxide production in primed cells. Antibodies to CD35 (CR1) also cause a minor calcium response in some individuals. Antibodies to CD11a, CD11b, CD11c, CD15, CD17, CD18, and CD45 do not activate monocytes. The ability of mAb to cause monocyte activation is not only dependent on the Ag with which they react but also on the isotype of the antibodies and the individual from whom the monocytes were obtained. It is shown that this is because the mAb that activate monocytes do so by formation of Ag-antibody-FcR complexes. F(ab')2 fragments of mAb to CD13 and CD14 do not therefore activate monocytes even when cross-linked with F(ab')2 anti-mouse Ig but do so when cross-linked with intact anti-mouse Ig. These data indicate that activation via the FcR requires perturbation of this receptor but does not necessarily require cross-linking of one FcR to another. Antibody-coated particles or cells able to bind to cell surface receptors on monocytes other than the FcR would thus augment FcR-mediated activation.


This article has been cited by other articles:


Home page
 Exp. Biol. Med.Home page
F. Nimura, L. F. Zhang, K. Okuma, R. Tanaka, H. Sunakawa, N. Yamamoto, and Y. Tanaka
Cross-linking cell surface chemokine receptors leads to isolation, activation, and differentiation of monocytes into potent dendritic cells.
Experimental Biology and Medicine, April 1, 2006; 231(4): 431 - 443.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
P. Mina-Osorio and E. Ortega
Aminopeptidase N (CD13) functionally interacts with Fc{gamma}Rs in human monocytes
J. Leukoc. Biol., June 1, 2005; 77(6): 1008 - 1017.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
Y. Drechsler, S. Chavan, D. Catalano, P. Mandrekar, and G. Szabo
Fc{gamma}R cross-linking mediates NF-{kappa}B activation, reduced antigen presentation capacity, and decreased IL-12 production in monocytes without modulation of myeloid dendritic cell development
J. Leukoc. Biol., October 1, 2002; 72(4): 657 - 667.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
K. Hattar, A. Bickenbach, E. Csernok, S. Rosseau, U. Grandel, W. Seeger, F. Grimminger, and U. Sibelius
Wegener's granulomatosis: antiproteinase 3 antibodies induce monocyte cytokine and prostanoid release--role of autocrine cell activation
J. Leukoc. Biol., June 1, 2002; 71(6): 996 - 1004.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1989 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1989 by The American Association of Immunologists, Inc. All rights reserved.